Document Detail


Optimal pharmacological stress testing for the diagnosis of coronary artery disease: a probabilistic approach.
MedLine Citation:
PMID:  8869117     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Previous reports have suggested that dobutamine stress echocardiography compares favourably with other stress agent-imaging modality combinations for the detection of coronary artery disease. However, in daily clinical practice the value of a test is defined on a probability basis. To study the relative diagnostic contribution of clinical and dobutamine stress test variables, Bayesian analysis was performed in 223 patients with suspected coronary artery disease, who underwent coronary angiography and a high-dose dobutamine stress test in conjunction with electrocardiography, echocardiography and Technetium-99m sestamibi SPECT myocardial perfusion scintigraphy. According to the pre-test (clinical) probabilities, patients were divided into low-, intermediate- and high-risk groups; 155 patients were in the intermediate-risk group. After dobutamine stress echocardiography the number of patients in this intermediate-risk group was reduced to 102 (P < 0.0001). This reduction of patients in the intermediate-risk group by echocardiography was better than perfusion scintigraphy (102 vs 126 patients, P < 0.05) or classic markers of ischaemia such as angina and/or ST-segment changes (102 vs 150, P < 0.0001). Moreover, there was a good correlation between the echocardiographic post-test probabilities and the true distribution of coronary artery disease.
Authors:
M L Geleijnse; T H Marwick; E Boersma; J W Deckers; J A Melin; P M Fioretti
Related Documents :
11773927 - Assessment of cardiac viability by thallium 201 redistribution and dobutamine echocardi...
9440077 - Cardiac rupture with dobutamine stress echocardiography.
19571347 - Echocardiography in 2009: state of the art.
9429827 - Objective echocardiographic evaluation of the cardiovascular system: state of the art.
3973267 - Clinical use of ultrashort-lived radionuclide krypton-81m for noninvasive analysis of r...
3103367 - Effects of halothane and enflurane on myocardial metabolism during postischaemic reperf...
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  European heart journal     Volume:  16 Suppl M     ISSN:  0195-668X     ISO Abbreviation:  Eur. Heart J.     Publication Date:  1995 Nov 
Date Detail:
Created Date:  1997-01-03     Completed Date:  1997-01-03     Revised Date:  2005-11-16    
Medline Journal Info:
Nlm Unique ID:  8006263     Medline TA:  Eur Heart J     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  3-10     Citation Subset:  IM    
Affiliation:
Thoraxcenter and Department of Nuclear Medicine, Erasmus University Rotterdam, Netherlands.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Aged
Coronary Disease / diagnosis*
Diagnostic Imaging
Dobutamine / diagnostic use*
Female
Humans
Male
Middle Aged
Probability
Stimulation, Chemical
Chemical
Reg. No./Substance:
34368-04-2/Dobutamine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Pharmacological agents for stress testing in the diagnosis of coronary artery disease.
Next Document:  Functional evaluation of patients with coronary artery disease: selection of appropriate pharmacolog...